Tetanus — Forgotten but Not Gone
- 23 March 1995
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 332 (12) , 812-813
- https://doi.org/10.1056/nejm199503233321209
Abstract
With so much concern about threats from emerging new infections and from antimicrobial resistance in common organisms, it is easy to become complacent about infections that are under control and have become clinical rarities. In this issue of the Journal, Gergen and colleagues1 provide the good news that almost 70 percent of a random sample of Americans six or more years of age had protective levels of tetanus antibodies. The bad news is that by the age of 60 to 69 years the prevalence of protective antibodies is less than 50 percent and, by the age of 70, about 30 . . .Keywords
This publication has 7 references indexed in Scilit:
- A Population-Based Serologic Survey of Immunity to Tetanus in the United StatesNew England Journal of Medicine, 1995
- Tetanus and botulinum-B neurotoxins block neurotransmitter release by proteolytic cleavage of synaptobrevinNature, 1992
- Treatment of tetanus: an open study to compare the efficacy of procaine penicillin and metronidazole.BMJ, 1985
- Tetanus toxin and synaptic inhibition in the substantia nigra and striatum of the rat.The Journal of Physiology, 1979
- TETANUS AND DIPHTHERIA ANTITOXIN LEVELS FOLLOWING A HOSPITAL-BASED ADULT IMMUNIZATION PROGRAM1American Journal of Epidemiology, 1975
- TETANUS—A PREVENTABLE DISEASEAnnals of Surgery, 1946
- TETANUS IN THE MIDDLE EAST EFFECTS OF ACTIVE IMMUNISATIONThe Lancet, 1942